Intellia, with first results, delivers a 'landmark' for CRISPR gene editing

Press/Media

Period	26 Jun 2021

Media coverage

Title	Intellia, with first results, delivers a 'landmark' for CRISPR gene editing
Media name/outlet	BioPharma Dive
Country/Territory	United States
Date	26/06/21
URL	https://www.biopharmadive.com/news/intellia-crispr-gene-editing-study-ttr-amyloidosis/602292/
Persons	Mary O'Donnell